Profile
Klaus Schwamborn served as Chief Development Officer at Pepscan Holding NV and Pepscan Therapeutics BV.
He also worked as Vice President-Discovery Research & Innovation at Valneva SE from 2013 to 2022.
Schwamborn holds a doctorate degree from the University of Gottingen.
Former positions of Klaus Schwamborn
| Companies | Position | End |
|---|---|---|
| VALNEVA | Corporate Officer/Principal | 2022-06-30 |
Pepscan Therapeutics BV
 Pepscan Therapeutics BV Pharmaceuticals: MajorHealth Technology Pepscan Therapeutics BV develops immunotherapeutic products in oncology. The company was founded in 2000 and is headquartered in Lelystad, the Netherlands. | Corporate Officer/Principal | - |
Pepscan Holding NV
 Pepscan Holding NV Pharmaceuticals: MajorHealth Technology Pepscan Holding NV operates as a holding company with interest in developing immunotherapeutic products in oncology. It offers proprietary technologies for the design, manufacture and use of large combinatorial arrays of peptides, peptide constructs, peptidometics and peptide derivatives. The firm operates through its subsidiaries Pepscan Systems BV and Pepscan Therapeutics BV. The company was founded in 2007 and is headquartered in Lelystad, the Netherlands. | Corporate Officer/Principal | - |
Training of Klaus Schwamborn
| University of Gottingen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VALNEVA | Health Technology |
| Private companies | 2 |
|---|---|
Pepscan Holding NV
Pepscan Holding NV Pharmaceuticals: MajorHealth Technology Pepscan Holding NV operates as a holding company with interest in developing immunotherapeutic products in oncology. It offers proprietary technologies for the design, manufacture and use of large combinatorial arrays of peptides, peptide constructs, peptidometics and peptide derivatives. The firm operates through its subsidiaries Pepscan Systems BV and Pepscan Therapeutics BV. The company was founded in 2007 and is headquartered in Lelystad, the Netherlands. | Health Technology |
Pepscan Therapeutics BV
Pepscan Therapeutics BV Pharmaceuticals: MajorHealth Technology Pepscan Therapeutics BV develops immunotherapeutic products in oncology. The company was founded in 2000 and is headquartered in Lelystad, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Klaus Schwamborn
